Novel drug targets are biomolecules or pathways that can be exploited to develop new therapeutic agents. These targets are often discovered through extensive research in genomics, proteomics, and bioinformatics. The identification of these targets is crucial for the development of targeted therapies, which aim to attack cancer cells while sparing healthy cells.